4
Changes in Ownership
Fulcrum Therapeutics, Inc. Filed Acc 0001140361-19-013355
10% owner acquired 1,785,714 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/form4.xml…